je.st
news
Tag: neck
Great Neck bridge, LIRR track extension clear MTA panel
2014-10-27 23:08:16| Railroads - Topix.net
A key MTA committee Monday approved a $24.9 million plan to replace a 115-year-old bridge near Great Neck and extend a track used to store Long Island Rail Road trains there. The Metropolitan Transportation Authority's Long Island Rail Road Committee Monday voted in favor of the contract, which will go before the full Metropolitan Transportation Authority Board for final approval Wednesday.
Neckspeaker Bluetooth speaker wraps around your neck
2014-10-09 21:58:19| Wireless - Topix.net
Wear your speakers around your neck! Quite bizarre, isn't it? Neckspeaker was unveiled at Ceatec, 2014 which is being held at Makuhari Messe.The speakers look like headphones, but actually they are wireless Bluetooth speakers that you can wear around your neck. Now you don't need those tangled ear plugs to groove to your favourite tunes! Neckspeaker also supports NFC pairing with your smartphone; it can be done very easily with a single touch.
Tags: bluetooth
speaker
neck
wraps
TCS, Cogizant now neck and neck in North America
2014-08-22 10:26:40| IT Services - Topix.net
Tata Consultancy Services , the country's largest IT services exporter, has regained revenue parity with its nearest competitor Cognizant in the key North American market, after trailing the latter for over three quarters, setting the stage for an interesting battle between the two companies in the world's largest technology market.
Product Launch - US: Captains Neck Brands' Captains Neck & Co
2014-06-19 11:41:43| Daily beverage news and comment - from just-drinks.com
Captains Neck Brands has launched a lightly carbonated and low-calorie beverage that intends to "capture the inviting and whimsical nature of summer on the East End of Long Island" in New York state.
Tags: co
product
brands
launch
First Presentation of Early Data for Pembrolizumab (MK-3475), Mercks Investigational Anti-PD-1 Antibody, in Advanced Head and Neck Cancer at ASCO 2014
2014-06-01 15:23:00| Merck.com - Corporate News
Dateline City: CHICAGO Overall Response Rate of 20 Percent for Pembrolizumab as Single Agent in Patients with Advanced Head and Neck Cancer Merck Initiating Phase 3 Study in Advanced Head and Neck Cancer with Pembrolizumab Versus Standard of Care in Q3 2014 (KEYNOTE-040) Additional 110 Patients with Advanced Head and Neck Cancer to be Enrolled in KEYNOTE-012 with Assessment of PD-L1 Tumor Levels Planned Pembrolizumab Announced as New Generic Name for MK-3475 CHICAGO--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of early findings from a Phase 1b study (KEYNOTE-012) evaluating pembrolizumab (MK-3475), Mercks investigational anti-PD-1 antibody, as a single-agent (monotherapy) in patients with PD-L1 positive, advanced head and neck cancer. Language: English Contact: MerckMedia Contacts:Ian McConnell, (973) 901-5722orClaire Mulhearn, (908) 423-7425orInvestor Contacts:Carol Ferguson, (908) 423-4465orJustin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
advanced
head
early
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »